165 related articles for article (PubMed ID: 22301782)
21. The zinc finger Ikaros transcription factor regulates pituitary growth hormone and prolactin gene expression through distinct effects on chromatin accessibility.
Ezzat S; Yu S; Asa SL
Mol Endocrinol; 2005 Apr; 19(4):1004-11. PubMed ID: 15618287
[TBL] [Abstract][Full Text] [Related]
22. Small Molecule, NSC95397, Inhibits the CtBP1-Protein Partner Interaction and CtBP1-Mediated Transcriptional Repression.
Blevins MA; Kouznetsova J; Krueger AB; King R; Griner LM; Hu X; Southall N; Marugan JJ; Zhang Q; Ferrer M; Zhao R
J Biomol Screen; 2015 Jun; 20(5):663-72. PubMed ID: 25477201
[TBL] [Abstract][Full Text] [Related]
23. An ARF/CtBP2 complex regulates BH3-only gene expression and p53-independent apoptosis.
Kovi RC; Paliwal S; Pande S; Grossman SR
Cell Death Differ; 2010 Mar; 17(3):513-21. PubMed ID: 19798104
[TBL] [Abstract][Full Text] [Related]
24. Fibroblast growth factor receptor 4 is a target for the zinc-finger transcription factor Ikaros in the pituitary.
Yu S; Asa SL; Ezzat S
Mol Endocrinol; 2002 May; 16(5):1069-78. PubMed ID: 11981041
[TBL] [Abstract][Full Text] [Related]
25. Downregulation of HERC5 E3 ligase attenuates the ubiquitination of CtBP1 to inhibit apoptosis in colorectal cancer cells.
Zhu L; Wu J; Liu H
Carcinogenesis; 2021 Aug; 42(8):1119-1130. PubMed ID: 34147029
[TBL] [Abstract][Full Text] [Related]
26. Epidermal growth factor receptor pathway substrate 8 is overexpressed in human pituitary tumors: role in proliferation and survival.
Xu M; Shorts-Cary L; Knox AJ; Kleinsmidt-DeMasters B; Lillehei K; Wierman ME
Endocrinology; 2009 May; 150(5):2064-71. PubMed ID: 19116338
[TBL] [Abstract][Full Text] [Related]
27. The CXCR4 antagonist AMD3100 suppresses hypoxia-mediated growth hormone production in GH3 rat pituitary adenoma cells.
Yoshida D; Koketshu K; Nomura R; Teramoto A
J Neurooncol; 2010 Oct; 100(1):51-64. PubMed ID: 20309720
[TBL] [Abstract][Full Text] [Related]
28. Functional characterization of DLK1/MEG3 locus on chromosome 14q32.2 reveals the differentiation of pituitary neuroendocrine tumors.
Chen Y; Gao H; Liu Q; Xie W; Li B; Cheng S; Guo J; Fang Q; Zhu H; Wang Z; Wang J; Li C; Zhang Y
Aging (Albany NY); 2020 Dec; 13(1):1422-1439. PubMed ID: 33472171
[TBL] [Abstract][Full Text] [Related]
29. LncRNA SNHG7 sponges miR-449a to promote pituitary adenomas progression.
Yue X; Dong C; Ye Z; Zhu L; Zhang X; Wang X; Mo F; Li Z; Pan B
Metab Brain Dis; 2021 Jan; 36(1):123-132. PubMed ID: 32880813
[TBL] [Abstract][Full Text] [Related]
30. CtBP1 transactivates RAD51 and confers cisplatin resistance to breast cancer cells.
Deng Y; Guo W; Xu N; Li F; Li J
Mol Carcinog; 2020 May; 59(5):512-519. PubMed ID: 32124501
[TBL] [Abstract][Full Text] [Related]
31. Transcriptional regulation by C-terminal binding proteins.
Chinnadurai G
Int J Biochem Cell Biol; 2007; 39(9):1593-607. PubMed ID: 17336131
[TBL] [Abstract][Full Text] [Related]
32. Ligand-dependent corepressor LCoR is an attenuator of progesterone-regulated gene expression.
Palijan A; Fernandes I; Verway M; Kourelis M; Bastien Y; Tavera-Mendoza LE; Sacheli A; Bourdeau V; Mader S; White JH
J Biol Chem; 2009 Oct; 284(44):30275-87. PubMed ID: 19744932
[TBL] [Abstract][Full Text] [Related]
33. AMP-activated protein kinase phosphorylates CtBP1 and down-regulates its activity.
Kim JH; Choi SY; Kang BH; Lee SM; Park HS; Kang GY; Bang JY; Cho EJ; Youn HD
Biochem Biophys Res Commun; 2013 Feb; 431(1):8-13. PubMed ID: 23291169
[TBL] [Abstract][Full Text] [Related]
34. Expression of phosphorylated p27(Kip1) protein and Jun activation domain-binding protein 1 in human pituitary tumors.
Korbonits M; Chahal HS; Kaltsas G; Jordan S; Urmanova Y; Khalimova Z; Harris PE; Farrell WE; Claret FX; Grossman AB
J Clin Endocrinol Metab; 2002 Jun; 87(6):2635-43. PubMed ID: 12050228
[TBL] [Abstract][Full Text] [Related]
35. Expression of neuro D1 in human normal pituitaries and pituitary adenomas.
Oyama K; Sanno N; Teramoto A; Osamura RY
Mod Pathol; 2001 Sep; 14(9):892-9. PubMed ID: 11557786
[TBL] [Abstract][Full Text] [Related]
36. Human pituitary adenomas express endogenous inhibin subunit and follistatin messenger ribonucleic acids.
Alexander JM; Swearingen B; Tindall GT; Klibanski A
J Clin Endocrinol Metab; 1995 Jan; 80(1):147-52. PubMed ID: 7829603
[TBL] [Abstract][Full Text] [Related]
37. β-arrestin expression in corticotroph tumor cells is modulated by glucocorticoids.
Gatto F; Feelders RA; van der Pas R; van Koetsveld P; Bruzzone E; Arvigo M; Dogan F; Lamberts S; Ferone D; Hofland L
J Endocrinol; 2020 Apr; 245(1):101-113. PubMed ID: 32027601
[TBL] [Abstract][Full Text] [Related]
38. Hypoxia induces hemorrhagic transformation in pituitary adenomas via the HIF-1α signaling pathway.
Xiao Z; Liu Q; Zhao B; Wu J; Lei T
Oncol Rep; 2011 Dec; 26(6):1457-64. PubMed ID: 21822544
[TBL] [Abstract][Full Text] [Related]
39. Rab3B immunoexpression in human pituitary adenomas.
Rotondo F; Scheithauer BW; Kovacs K; Bell DC
Appl Immunohistochem Mol Morphol; 2009 May; 17(3):185-8. PubMed ID: 19384079
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-137 targets carboxyl-terminal binding protein 1 in melanoma cell lines.
Deng Y; Deng H; Bi F; Liu J; Bemis LT; Norris D; Wang XJ; Zhang Q
Int J Biol Sci; 2011 Jan; 7(1):133-7. PubMed ID: 21278922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
